News
-
-
PRESS RELEASE
Clinical Trials to get Underway with Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test - A Potential Game Changer to Address Syphilis Health Crisis in Canada
MedMira Inc. announces full clinical trials for Multiplo® Complete Syphilis (TP/nTP) Antibody Test in Canada with REACH Nexus at MAP Centre for Urban Health Solutions. The innovative test combines screening and confirmation in under 3 minutes -
-
-
-
-
-
-
-
PRESS RELEASE
MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System
MedMira Inc. announces the receipt of a Canadian patent for a new quantitative test system using Rapid Vertical Flow Technology, enhancing its diagnostic tests. The system offers qualitative and quantitative results in minutes, revolutionizing disease screening and monitoring